Andrea Prinzi, PhD, MPH, SM(ASCP)


Are We at a Breaking Point for Adoption of Updated Susceptibility Interpretive Criteria?

The implementation of new College of American Pathologists rules presents an opportunity for collaboration between clinical microbiology laboratories and infectious disease pharmacists and physicians.

Jordan Mayberry, PA-C, MPAS


Treatment Options for HCV

An overview of treatment regimens for HCV.

© 2023 MJH Life Sciences

All rights reserved.